Eiken Chemical Co., Ltd.
【Eiken Chemical】Opposition to Shareholder Proposal ｜ May 2026
Eiken Chemical has resolved to oppose the shareholder proposal as a Board of Directors. The proposal concerns the appointment of two directors, citing concerns over independence and potential conflicts of interest. The review of management strategies and medium-term plans has been separately disclosed.
Key Figures
- Shareholder Proposal Holder's Shareholding Ratio: 32.84%
- Dalton Advisory's Shareholding Ratio: 19.75%
- Number of Shares Held by Proposed Candidate: 0 shares
AI要約
Board of Directors' Opinion on the Shareholder Proposal
Eiken Chemical received a proposal from shareholders on April 14, 2026, to appoint two directors, and the Board of Directors resolved to oppose it. The proposer is affiliated with Dalton Advisory, and concerns over independence and conflicts of interest are cited. The Board of Directors considers that the proposed candidates do not meet the company's independence standards and could harm shareholder interests.
Future Management Policies and Corporate Strategies
Eiken Chemical announced a new management plan in April 2026, aiming for sustainable growth and enhancement of corporate value. The medium-term management plan focuses on expanding high-value-added sectors and strengthening overseas operations, with proactive consideration of alliances and M&A. The Board of Directors has determined that the current management structure and the appointment of candidates will maintain optimal governance.
Eiken Chemical Co., Ltd.
Company overview · Stock price · Financial data · All IR
